Leerink Partnrs Forecasts Weaker Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities researchers at Leerink Partnrs reduced their FY2025 earnings per share estimates for shares of Henry Schein in a note issued to investors on Tuesday, November 5th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $5.20 per share for the year, down from their prior forecast of $5.31. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's FY2026 earnings at $5.67 EPS and FY2027 earnings at $6.22 EPS.

A number of other equities analysts have also weighed in on HSIC. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Baird R W upgraded Henry Schein from a "hold" rating to a "strong-buy" rating in a report on Monday, July 22nd. UBS Group decreased their target price on Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a research report on Monday, August 12th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $77.50.

Henry Schein Trading Down 1.6 %

Shares of HSIC stock traded down $1.10 during trading hours on Friday, hitting $68.33. 290,454 shares of the company were exchanged, compared to its average volume of 1,354,568. Henry Schein has a 1 year low of $62.12 and a 1 year high of $82.63. The firm has a fifty day moving average of $70.56 and a 200 day moving average of $69.78. The firm has a market cap of $8.66 billion, a PE ratio of 25.71, a PEG ratio of 2.08 and a beta of 0.87. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm's revenue for the quarter was up .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.32 EPS.

Institutional Trading of Henry Schein

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Cromwell Holdings LLC increased its stake in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after acquiring an additional 170 shares during the period. Summit Securities Group LLC bought a new stake in shares of Henry Schein in the 2nd quarter worth $31,000. Beach Investment Counsel Inc. PA acquired a new stake in shares of Henry Schein in the second quarter valued at $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after buying an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after acquiring an additional 346 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.